FDA Inspection 788357 — Hyphen BioMed sasu

Hyphen BioMed sasu — FEI 3004434070

The FDA completed an inspection of Hyphen BioMed sasu on June 20, 2012 in Neuville-Sur-Oise. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 20, 2012
Fiscal Year
2012
Product Type
Devices
Project Area
Compliance: Devices
Location
Neuville-Sur-Oise (France)

Citations

IDCFRDescription
1472221 CFR 820.40Procedures not adequately established or maintained
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
315921 CFR 820.184DHR content
323321 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
328521 CFR 820.90(b)(2)Product rework procedures, Lack of or inadequate procedures